AIMP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.549200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.364600E-01
Normal-vs-Stage2
5.220200E-01
Normal-vs-Stage3
6.060600E-01
Normal-vs-Stage4
3.039000E-01
Stage1-vs-Stage2
7.091400E-01
Stage1-vs-Stage3
2.660000E-01
Stage1-vs-Stage4
3.244400E-01
Stage2-vs-Stage3
1.352750E-01
Stage2-vs-Stage4
5.444800E-01
Stage3-vs-Stage4
1.565030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.832400E-01
Normal-vs-AfricanAmerican
6.066600E-01
Normal-vs-Asian
2.890400E-01
Caucasian-vs-AfricanAmerican
8.814400E-01
Caucasian-vs-Asian
1.997960E-01
AfricanAmerican-vs-Asian
3.426000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.476400E-01
Normal-vs-Female
5.754400E-01
Male-vs-Female
8.598800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.983200E-01
Normal-vs-Age(41-60Yrs)
4.088600E-01
Normal-vs-Age(61-80Yrs)
6.928400E-01
Normal-vs-Age(81-100Yrs)
1.403560E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.073800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.911200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.375400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.194850E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.514200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.830970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.469600E-01
Normal-vs-Daily Drinker
8.439800E-01
Normal-vs-Weekly Drinker
5.088400E-01
Normal-vs-Occasional Drinker
3.905200E-01
Normal-vs-Social Drinker
3.967200E-01
Non Drinker-vs-Daily Drinker
8.377200E-01
Non Drinker-vs-Weekly Drinker
3.176000E-01
Non Drinker-vs-Occasional Drinker
3.970800E-01
Non Drinker-vs-Social Drinker
2.713800E-01
Daily Drinker-vs-Weekly Drinker
2.317600E-01
Daily Drinker-vs-Occasional Drinker
3.452400E-01
Daily Drinker-vs-Social Drinker
2.553600E-01
Weekly Drinker-vs-Occasional Drinker
5.837400E-01
Weekly Drinker-vs-Social Drinker
7.631400E-01
Occasional Drinker-vs-Social Drinker
7.067800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.136400E-01
Normal-vs-Grade 2
7.828000E-01
Normal-vs-Grade 3
8.191600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.770310E-02
Grade 1-vs-Grade 3
3.697600E-03
Grade 1-vs-Grade 4
7.136400E-01
Grade 2-vs-Grade 3
1.533150E-01
Grade 2-vs-Grade 4
7.828000E-01
Grade 3-vs-Grade 4
8.191600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.344800E-01
Normal-vs-NonDiabetic
4.834400E-01
Diabetic-vs-NonDiabetic
1.295650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.563800E-01
Normal-vs-NoPancreatitis
5.899400E-01
Pancreatitis-vs-NoPancreatitis
4.534600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.149200E-01
Normal-vs-N1
5.583600E-01
N0-vs-N1
9.789800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.700210E-01
Normal-vs-TP53-NonMutant
7.648200E-01
TP53-Mutant-vs-TP53-NonMutant
8.952100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
